Observational studyPloS one2016

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.

Amedeo F Capetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.